Boston Therapeutics and SUGARDOWN®
The company has submitted structure and function claims for its first consumer product trademarked SUGARDOWN®. Those concerned about high blood sugar and carbohydrate intake may find SUGARDOWN® an effective dietary supplement.
All components of SUGARDOWN® are GRAS certified (Generally Regarded As Safe), and SUGARDOWN® is registered with the United States Food and Drug Administration (FDA).
We want to provide effective and safe products for our customers that help them improve their health and foster a healthy lifestyle.
Company founders have extensive expertise in complex carbohydrate chemistry, manufacturing, regulatory and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration and Environmental Protection Agency. The founders also provide over 50 years of combined expertise in public and private business entities management, banking, marketing and sales.
Many dietary supplements have a long list of ingredients which are difficult to measure or source. Their ingredients may have possible interaction between themselves or with other supplements or with drugs. Boston Therapeutics promises you that SUGARDOWN®’s proprietary chemistry is based on the philosophy of employing simplicity, quality and validation in product development and manufacturing.
While other supplements imply prevention or treatment claims by stating that they increase cell sensitivity to insulin, support insulin production, or support good pancreatic, brain, liver, blood activity, we state that SUGARDOWN® is non-systemic, works in the digestive system and has no role in removing sugar from the blood by these other means. SUGARDOWN® as a functional dietary supplement, has a non-systemic role to keep glucose from being released from complex carbohydrates from food during digestion.
To summarize, SUGARDOWN® doesn’t remove sugar from the blood: SUGARDOWN®’s non-systemic activity simply keeps blood sugar from going up considerably in the first place.